Clinical Trial Update: Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of guadecitabine plus atezolizumab in adults with advanced myelodysplastic syndrome or chronic myelomonocytic leukemia that is refractory or rel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia with Myelodysplasia-related Changes
• Myelodysplastic Syndrome
• Myelomonocytic Leukemia

Drugs mentioned

• Atezolizumab (Tecentriq) (atezolizumab)
• Guadecitabine (SGI-110) (guadecitabine)

Snippet

Sponsor: University of Southern California | Conditions: Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING